METHODS:
For the MPC grafting, tibial inserts were placed in the MPC aqueos solution (0.5 mol/L), and photoinduced polymerization on the surface (strong C-C covalent bonding between the grafted layer and the substrate) was carried out with UV-irradiation of 5 mW/cm 2 for 90 min at 60°C. The hydrophilicity of the PE surface was determined by the contact angle of a water droplet, and the friction torque was measured against the cobalt-chromium (Co-Cr) alloy ball. To assess the amount of wear, the knee joint wear simulator test was performed under the conditions recommended by ISO 14243 using a 6-station knee joint simulator apparatus with 6-mm-thick PE, CLPE, or MPC-grafted CLPE (MPC-CLPE) tibial inserts against the Co-Cr alloy femoral component. A mixture of 27% calf serum was used as lubricant. The gravimetric wear was determined by weighing the tibial insert, according to ISO 14243-2. The weights of the inserts were measured every 0.5 × 10 6 cycles. Data of load-soak controls were used to compensate for the fluid absorption by the wear samples. The testing was continued until a total of 5.0 × 10 6 cycles were completed (comparable to 5 to 10 years of physical walking). The volumetric wear and surface morphology of the insert were measured by a 3-dimensional morphometric and the laser microscopic analyses at the end of the experiment. For the isolation of wear particles, the lubricant after the loading was incubated with 5 N NaOH solution in order to digest adhesive proteins that were degraded and precipitated; the particles were then collected and underwent sequential filtrations. The size of particles was defined as the maximum dimensions by SEM analysis. To evaluate the mechanical properties of the tibial inserts before and after the loading, the small punch test was performed, according to ASTM F2183-02.
RESULTS:
The contact angles of a water drop on the MPC-CLPE surface were about 1/3 those of the CLPE surface, indicating that MPC grafting increased hydrophilicity. Although the cross-linking by itself did not alter the friction torque, the MPC grafting on the CLPE surface decreased it by more than 80%. This is probably because the lubricity was markedly improved by the hydrated lubricating layer that was formed by MPC grafting. The gravimetric wear (mg) after 5 X 10 6 cycles of loading in the knee joint simulator was PE/Co-Cr= 12.7 ± 7.2, CLPE/Co-Cr= 1.6 ± 1.8, and MPC-CLPE/Co-Cr= -2.7 ± 1.0. The weight gain in the MPC-CLPE inserts was confirmed to be due to water absorption, since it was similarly seen in all liners with and without MPC grafting during load-soak in the lubricant. Time course of threedimensional morphometric analyses of medial and lateral surfaces of the three kinds of tibial inserts confirmed the wear resistance by the crosslinking and MPC grafting. During loading up to 5 x 10 6 cycles, the cross-linking increased the wear resistance as compared to the noncross-linked PE, and the MPC grafting further enhanced it. Confocal scanning laser microscopic analyses of the insert surfaces revealed that the original machine marks that were clearly visible before the loading still remained on the MPC-CLPE surfaces even after 5 x 10 6 cycles, while they were completely obliterated not only on the non-cross-linked PE, but also on the CLPE surfaces. The amounts shown by the total number and area of particles were decreased by cross-linking, and were almost abrogated by the MPC grafting (Figure 1 ). The mechanical properties of the insert material were not affected by the MPC grafting and remained unchanged during the loading regardless of cross-linking or MPC grafting. 
DISCUSSION:
The lines of results obtained in this study clearly demonstrate that the biocompatible phospholipid polymer MPC grafted onto the tibial insert surface of a knee prosthesis decreased the friction and increased the wear resistance in the knee joint simulator experiment, indicating that this approach is promising to extend the longevity of artificial knee joints, similarly to the artificial hip joints as we previously reported.
The MPC polymer is our original biocompatible polymer, which has the same polar group (phospholylcholine group) as the biomembrane. Hence, the MPC grafting onto the surface of other medical devices has already been shown to suppress biological reactions even when they are in contact with living organisms, and is now clinically used on the surfaces of intravascular stents, intravascular guide wires, soft contact lenses and the artificial lung under the authorization of the Food and Drug Administration (FDA). In addition, our previous study revealed MPC nanoparticles were hardly phagocytosed by macrophages and did not induce the production of bone resorptive cytokines. Furthermore, the culture medium of macrophages exposed to MPC nanoparticles did not induce osteoclast formation from bone marrow cells. These results suggest that MPC particles are biologically inert in respect to phagocytosis by macrophages and subsequent bone resorptive actions.
From the advantages shown in this study, we believe hat the MPC grafting will make a significant improvement in total joint replacements by preventing periprosthetic osteolysis and aseptic loosening not only in hip, but also in knee. Considering the urgent needs for development of artificial knee joints with longevity, this nanotechnology would improve the quality of care of patients having joint replacement and have a substantial public health impact. In addition to the large-scale clinical trial of artificial hip joints which is now underway, we are currently designing the same size of trial for artificial knee joints.
